Multinational drug makers to face FTC scrutiny

Foreign-invested pharmaceutical firms will come under the scrutiny of the Fair Trade Commission as the Ministry of Health and Welfare has recently requested the FTC to demand these firms' unfair business code.

In a meeting on June 20 where representatives from the government, multinational drug manufacturers, Zuellig Pharma Korea, Korea Pharmaceutical Wholesalers Association and Korea Pharma...